AMPH Market Cap History
Below is a table of the AMPH market cap history going back to 6/25/2014:

Date AMPH Market Cap
6/25/2014374.20M
8/8/2014446.44M
11/10/2014447.83M
3/8/2015658.67M
5/11/2015653.87M
8/10/2015701.82M
11/9/2015570.40M
3/8/2016500.79M
5/3/2016549.36M
8/2/2016729.61M
11/2/2016840.39M
3/8/2017680.85M
5/3/2017682.41M
8/2/2017741.91M
11/2/2017851.47M
3/6/2018831.07M
5/3/2018862.36M
8/2/2018798.85M
11/2/2018865.27M
3/8/20191.11B
5/3/20191.05B
8/2/2019938.39M
11/1/2019918.11M
3/9/2020673.23M
8/3/2020984.85M
11/2/2020945.33M
3/8/2021851.90M
5/3/2021833.14M
8/2/20211.02B
11/2/2021920.14M

Also see: AMPH Shares Outstanding History
and AMPH YTD Return
AMPH Historical Market Cap:
+13.00% CAGR
AMPH Historical Market Cap: +13.00% CAGR

Mouse over chart for data details
6/25/2014 ...11/2/2021
Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, enoxaparin, naloxone, phytonadione, lidocaine, as well as various other critical and non-critical care drugs; and API products, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development. We show 30 historical shares outstanding datapoints in our AMPH shares outstanding history coverage, used to compute AMPH market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AMPH market cap history over the course of time is important for investors interested in comparing AMPH's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AMPH versus a peer is one thing; comparing AMPH market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AMPH can fluctuate over the course of history. With this page we aim to empower investors researching AMPH by allowing them to research the AMPH market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AMPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Amphastar Pharmaceuticals (AMPH) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AMRX Market Cap History
AMTI Market Cap History
ANAB Market Cap History
ANAC Market Cap History
ANEB Market Cap History
ANGN Market Cap History
ANGO Market Cap History
ANIK Market Cap History
ANIP Market Cap History
ANIX Market Cap History
More Healthcare companies »

 

AMPH Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.